History
  • No items yet
midpage
Dr. Jesse Smith, M.D. v. Crestview NuV, LLC, on Its Own Behalf and Derivatively on Behalf of NuVivo Bioscience Solutions, LLC.
565 S.W.3d 793
Tex. App.
2018
Read the full case

Background

  • Crestview invested $500,000 in NuVivo Bioscience Solutions (NBS) based on representations by Mary Armstrong about product development, clinical involvement, and imminent sales; later discovered significant personal spending and no product sales.
  • Armstrong alleged Dr. Jesse Smith served as NBS medical consultant and had conducted clandestine injections/testing of the product; Crestview sought relief against Armstrong and later added Smith under the Texas Securities Act (TSA) as an aider under art. 581-33(F)(2).
  • Crestview’s amended petition pleaded aider liability based on Smith’s actions (conducting testing, failing to keep medical records, violating medical-board rules) rather than any alleged statements or disclosures by Smith.
  • Smith filed a TCPA (anti‑SLAPP) motion to dismiss, arguing the claim targeted his rights to free speech and association because it implicated communications and common-interest association with Armstrong; the trial court denied by operation of law and then formally.
  • On appeal Smith argued (1) he met the TCPA movant burden by showing Crestview’s claim involved protected communications/association, and (2) Crestview failed to produce prima facie evidence of aider liability. The court reviewed de novo and focused on whether the pleaded claim alleged a “communication.”

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Crestview’s TSA aider claim is based on a protected "communication" under the TCPA Crestview: Claim is fact-based conduct (aider acts), not a communication; TCPA does not apply. Smith: The aider claim necessarily rests on communications/consulting about the product and association with Armstrong, so TCPA applies. Held: TCPA inapplicable — Crestview pleaded only conduct (testing, recordkeeping violations), not the making/submitting of statements or documents.
Whether Crestview failed to present prima-facie evidence of aider liability under the TSA (if TCPA applied) Crestview: Allegations suffice to state aider liability elements against Smith. Smith: Even if TCPA applies, Crestview cannot meet its burden to prove each aider-element. Held: Court did not reach merits of this issue because TCPA did not apply; second issue left undecided.

Key Cases Cited

  • In re Lipsky, 460 S.W.3d 579 (Tex. 2015) (preponderance standard and TCPA burden-shifting framework)
  • Hersch v. Tatum, 526 S.W.3d 462 (Tex. 2017) (pleadings are best evidence of the nature of a claim in TCPA context)
  • Adams v. Starside Custom Builders, LLC, 547 S.W.3d 890 (Tex. 2018) (broad definition of "communication" under TCPA)
  • Lippincott v. Whisenhunt, 462 S.W.3d 507 (Tex. 2015) (statutory interpretation of TCPA definitions)
  • Elite Auto Body LLC v. Autocraft Bodywerks, 520 S.W.3d 191 (Tex. App.—Austin 2017) (trade-secret claims subject to TCPA only when they allege disclosure/communication)
Read the full case

Case Details

Case Name: Dr. Jesse Smith, M.D. v. Crestview NuV, LLC, on Its Own Behalf and Derivatively on Behalf of NuVivo Bioscience Solutions, LLC.
Court Name: Court of Appeals of Texas
Date Published: Nov 29, 2018
Citation: 565 S.W.3d 793
Docket Number: 02-18-00220-CV
Court Abbreviation: Tex. App.